vimarsana.com
Home
Live Updates
Boan Biotech Announces 2022 Financial Results, Showing Accel
Boan Biotech Announces 2022 Financial Results, Showing Accel
Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
YANTAI, CHINA - Media OutReach - 28 March 2023 - Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023. 2022 business...
Related Keywords
Yantai ,
Shandong ,
China ,
Singapore ,
Shenzhen ,
Guangdong ,
Hong Kong ,
Shanghai ,
Jiang Hua ,
Hunan ,
Chinese ,
Sino Biopharm ,
Phage Display Technology Platform ,
Astrazeneca ,
National Reimbursement Drug List ,
Bispecific Engager Technology Platform ,
Technology Platform ,
Boan Biotech ,
Biological License Application ,
Main Board ,
Hong Kong Stock Exchange ,
Shanghai Hong Kong Stock Connect ,
Shenzhen Hong Kong Stock Connect ,
Reimbursement Drug List ,
Human Antibody Transgenic Mouse ,
Phage Display Platform ,
Bispecifict Cell Engager Platform ,
Antibody Drug Conjugate ,
Chief Executive Officer ,
Bispecifict Cell Engager Technology Platform ,
Taboan ,
Biotech ,
Announces ,
2022 ,
Financial ,
Results ,
,
Showing ,
Aaccelerated ,
Innovation ,
Hand ,
Strong ,
225 ,
Revenue ,
Growth ,